“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
Medical Design and Outsourcing2d
NAMSA acquires WuXi’s U.S. manufacturing facilities
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...
WuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target Price
CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...
pharmaphorum1d
MSD buys Irish vaccines plant from WuXi for €500m
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
pharmaphorum22h
Why Ireland has emerged as Europe’s biopharma hotspot
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm ...
Dundalk Democrat4d
What the state-of-art €325 million WuXi Biologics Dundalk plant may look like
If you want further access to Ireland's best local journalism ... The Investment Promotion & Development Agency (IDA) has revealed mock-up drawings of what the new WuXi Biologics plant in Dundalk ...
Morningstar3d
China Pharma Group WuXi Gains as Trump's TikTok Move Buoys Mood
Shares of WuXi group companies jumped Monday after U.S. President-elect Trump promised to save TikTok and held a call with his counterpart in China, sparking tentative hopes that some areas of U.S ...